Thromboprophylaxis for outpatients with COVID-19: a Systematic Review and Meta-analysis Cho-Han ChiangOmer AhmedCho-Hung Chiang BriefCommunication 26 April 2024
Endovascular thrombectomy in wake-up stroke guided by arterial spin-labeling and fluid-attenuated inversion recovery versus diffusion-weighted imaging mismatch on MRI Hong-Feng WenQin LiJi-Chen Du OriginalPaper 25 April 2024
The foundation for investigating factor XI as a target for inhibition in human cardiovascular disease Ahmed E. AliRichard C. Becker ReviewPaper Open access 25 April 2024
Layered plaque is associated with high levels of vascular inflammation and vulnerability in patients with stable angina pectoris Takayuki NiidaDaisuke KinoshitaIk-Kyung Jang OriginalPaper 22 April 2024
Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases Julie WangPrahlad HoHui Yin Lim ReviewPaper 22 April 2024
Equivalent thrombotic risk with Warfarin, Dabigatran, or Enoxaparin after failure of initial direct oral anticoagulation (DOAC) therapy Margaret ShyuAngela LiuLeonard Naymagon OriginalPaper 21 April 2024
Comparison of the PADUA and IMPROVE scores in assessing venous thromboembolism risk in 42,257 medical inpatients in China Hou YifangDuan JunDeng Xiaomei OriginalPaper 21 April 2024
Impaired fibrinolysis in patients with atrial fibrillation and elevated circulating lipopolysaccharide Marcin SadowskiMichał ZąbczykAnetta Undas OriginalPaper Open access 21 April 2024
Haemostatic gene variations in cervical cancer-associated venous thrombosis: considerations for clinical strategies Beatriz Vieira NetoValéria TavaresRui Medeiros OriginalPaper 20 April 2024
Primary thromboprophylaxis in cancer outpatients – real-world evidence Joana Liz-PimentaValéria TavaresRui Medeiros OriginalPaper 20 April 2024
Factor XI: structure, function and therapeutic inhibition Ahmed E. AliRichard C. Becker ReviewPaper Open access 16 April 2024
Intravenous antiplatelet therapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Angelo SilverioMichele BellinoGennaro Galasso OriginalPaper 13 April 2024
Evaluation of modified fixed dose four-factor prothrombin complex concentrate for warfarin reversal Meghan E. PetersonMegan P. JaynesColleen Morton OriginalPaper 06 April 2024
Management of DOAC-related bleeding in cancer patients: a single center-case series Sophia LeeJeremy A. RossCristhiam M. Rojas Hernandez OriginalPaper 31 March 2024 Pages: 677 - 682
One-year morbidity and mortality in patients treated with standard-dose and low-dose apixaban after acute large vessel occlusion stroke Yasutaka MurakamiKenichi TodoHideki Mochizuki OriginalPaper Open access 31 March 2024 Pages: 622 - 629
Impact of rise and fall phases of shear on platelet activation and aggregation using microfluidics Xuemei GaoTiancong ZhangYuan Li OriginalPaper 31 March 2024 Pages: 576 - 586
Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome Yee-Jen WuChien-Chih WuChi-Chuan Wang OriginalPaper 31 March 2024 Pages: 537 - 546
Thromboembolic events after major bleeding events in patients with mechanical heart valves: a 13-year analysis Pascal AugustinStefan AndreiPhilippe Montravers OriginalPaper 31 March 2024
Management of direct oral anticoagulant drug interactions in hospitalized patients Mohsen H. Al ZariaLeo F. BuckleyJohn Fanikos OriginalPaper 30 March 2024 Pages: 598 - 602
COVID-19 vaccination affects short-term anti-coagulation levels in warfarin treatment Li-Hua LiuYang-Zhao ZhouSheng-Lan Tan OriginalPaper 25 March 2024 Pages: 730 - 738
Persistent hypofibrinolysis in severe COVID-19 associated with elevated fibrinolysis inhibitors activity Erica OkazakiBárbara Gomes BarionFernanda Andrade Orsi OriginalPaper 25 March 2024 Pages: 721 - 729
Benefit and risk of oral anticoagulant initiation strategies in patients with atrial fibrillation and cancer: a target trial emulation using the SEER-Medicare database Bang TruongLori HornsbyJingjing Qian OriginalPaper Open access 20 March 2024 Pages: 638 - 649
Outcomes of venous thromboembolism in patients with inherited thrombophilia treated with direct oral anticoagulants: insights from the RIETE registry Omri CohenGili Kenetand the RIETE investigators OriginalPaper 16 March 2024 Pages: 710 - 720
Superficial vein thrombosis and its relationship with malignancies: a prospective observational study Alejandro DÃez-VidalJavier Gómez LópezYale Tung-Chen OriginalPaper 16 March 2024 Pages: 650 - 657
Antithrombotic strategies for preventing graft failure in coronary artery bypass graft Maria Sara MauroSimone FinocchiaroDavide Capodanno ReviewPaper Open access 16 March 2024 Pages: 547 - 557
Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model Mario AramberriJesús González-OlmedoCarmen Diaz-Pedroche OriginalPaper 14 March 2024 Pages: 668 - 676
Anticoagulation control among patients on vitamin K antagonists in nine countries in Sub-Saharan Africa Julius Chacha MwitaJoel Msafiri FrancisKaren Cohen OriginalPaper Open access 13 March 2024 Pages: 613 - 621
Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory Paul A. GurbelKevin BlidenUdaya S. Tantry OriginalPaper 13 March 2024 Pages: 566 - 575
The incidence of major bleeding in adult patients with urogenital and gynecological cancer being treated with direct oral anticoagulants (DOACs): a systematic review L. Al-TourahS. MithoowaniRick Ikesaka OriginalPaper 01 March 2024 Pages: 630 - 637
Is a minimum duration of 5 days of unfractionated heparin infusion necessary before transition to oral anticoagulation in cerebral venous thrombosis? a retrospective chart review Ariel N. CarrionTeresa A. AllisonSophie Samuel OriginalPaper 28 February 2024 Pages: 691 - 698
Discrimination of the acute pulmonary embolism subtypes based on the novel MAPH score Onur AkhanMustafa BozMehmet Kis OriginalPaper 28 February 2024 Pages: 683 - 690
Retrospective, multicenter analysis of the safety and effectiveness of direct oral anticoagulants for the treatment of venous thromboembolism in obesity Jeffrey D. SperryAletha LoebJennifer A. Szwak OriginalPaper 26 February 2024 Pages: 603 - 612
A systematic review of therapeutic enoxaparin dosing in obesity Maya R. ChilbertKimberly ZammitAshley E. Woodruff ReviewPaper 25 February 2024 Pages: 587 - 597
Therapeutic implication of MicroRNA-320a antagonist in attenuating blood clots formed during venous thrombosis Swati SrivastavaIti GargRajeev Varshney OriginalPaper 23 February 2024 Pages: 699 - 709
A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants Benjamin WeeJeffrey LaiBrandon Lui OriginalPaper 23 February 2024 Pages: 658 - 667
Impact of hemodialysis on efficacies of the antiplatelet agents in coronary artery disease patients complicated with end-stage renal disease Zekang YeQin WangChunjian Li OriginalPaper Open access 23 February 2024 Pages: 558 - 565
Effect of continuous 2 MHz transcranial ultrasound as an adjunct to tenecteplase thrombolysis in acute anterior circulation ischemic stroke patients: an open labeled non-randomized clinical trial Semparuthi ArumughamSunil K. NarayanRajeswari Aghoram OriginalPaper 23 February 2024
Enoxaparin is not an oral factor Xa inhibitor. Response to Sutton et al. real-world clinical outcomes among US veterans with oral factor Xa inhibitor–related major bleeding treated with andexanet alfa or 4-factor prothrombin complex concentrate Richard J BukaDavid J SuttonPhillip LR Nicolson Letter to the Editor 15 February 2024 Pages: 739 - 741
Blood group AB is associated with reduced blood loss but also elevated cardiovascular mortality in aortocoronary bypass surgery Franz MasseliArlinda VeseliWolfgang Schiller OriginalPaper Open access 12 February 2024 Pages: 512 - 519
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study Diona GjermeniViktoria AnfangChristoph B. Olivier OriginalPaper Open access 12 February 2024 Pages: 361 - 369
Remote intensive management to improve antiplatelet adherence in acute myocardial infarction: a secondary analysis of the randomized controlled IMMACULATE trial Hui Wen SimKaren W. L. KohMark Y. Chan OriginalPaper 01 February 2024 Pages: 408 - 417
Proteomics associated with coronary high-risk plaques by optical coherence tomography Takayuki NiidaHaruhito YukiIk-Kyung Jang OriginalPaper 31 January 2024 Pages: 204 - 211
Treating periprocedural bleeding in patients with cirrhosis Antoni SabateEcaterina Scarlatescu ReviewPaper Open access 28 January 2024 Pages: 531 - 536
Different drugs in drug-eluting stents for peripheral artery disease: a systematic evaluation and Bayesian meta-analysis Keqin ChenLei XuXiehong Liu ReviewPaper 28 January 2024 Pages: 520 - 530
Prospective analysis of pre and postoperative laboratory parameters associated with thrombosis in patients with ovarian cancer Hyoeun ShimJi Hyun KimSun-Young Kong BriefCommunication 28 January 2024 Pages: 492 - 496
Trends of Pulmonary Embolism-Related Sudden Cardiac Death in the United States, 1999–2019 Marco ZuinThure Filskov OvervadGregory Piazza OriginalPaper 28 January 2024 Pages: 483 - 491
Computed tomography-based radiomics model to predict adverse clinical outcomes in acute pulmonary embolism Fei YangRong ChenDawei Wang OriginalPaper 28 January 2024 Pages: 428 - 436
Anticoagulant prescribing patterns in patients with primary central nervous system malignancies and secondary metastases Emily AbdelmessihTania AhujaElaine Xiang OriginalPaper 28 January 2024 Pages: 418 - 427
Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation and stage 5 chronic kidney disease under dialysis: A systematic review and meta-analysis of randomized controlled trials Larissa A. de LucenaMarcos A. A. FreitasRodrigo A. de Oliveira OriginalPaper 28 January 2024 Pages: 381 - 389
Antiplatelet therapy in elderly patients with ACS: moving targets need more tailored treatments Antonio Landi Letter to the Editor 28 January 2024 Pages: 358 - 360
